Dollar Tree has caught the repricing wave and will meet with lenders next week to discuss new terms for a $3.95 billion term loan B, including splitting up the borrowings between floating and fixed-rate tranches.
Investors added to bank loan mutual funds for second consecutive week, while bond funds returned to favor after suffering four consecutive weeks of withdrawals.
Despite plans to raise $13 billion of new incremental debt through the transaction, CVS Health Corp. is not expected to face a downgrade from its investment grade status following its agreement to purchase Omnicare Inc. for $12.7 billion.
Houston-based power company Calpine is returning to the capital markets with a $1.65 billion term loan offering, according to reports and KDP Investment Advisors.
Endo International has received debt financing commitments from Deutsche Bank and Barclays for its $8.05 billion cash-and-stock acquisition of Par Pharmaceutical announced Monday, according to a release from Endo.
Blue Coat Systems has resized a term loan proposal to $1.15 billion, from $1.05 billion, and downsized a notes offering to $470 million to help finance its buyout by Bain Capital.
Last month, the coal producer elected to use a 30-day grace period to delay interest payments on two of its bond issues, triggering rating agency downgrades. However, it remains to be seen if the company will negotiate with investors or file for bankruptcy.
The package, which includes a $365 million, seven-year loan, is intended to help fund the companys acquisition of Optim Healthcare, had final terms of Libor plus 350 bps
Investors added $393.5 million to bank loan funds, but continued their withdrawals from high yield bond funds for the fourth consecutive week.
Price talk has emerged on a $1.5 billion term loans tranche of a $2.1 billion debt offering Epicor Software is fronting to fund a dividend and refinance debt in advance of a business units spin-off.